Abionic
1 known investors
Abionic develops the abioSCOPE, a nanofluidics-based rapid diagnostics platform that runs a PSP biomarker assay to detect sepsis from a drop of blood within minutes. The system is aimed at emergency and critical care clinicians to enable earlier sepsis detection and intervention.
Deep TechDigital HealthMedical Devices
Investors · 1
Frequently asked questions
- What does Abionic do?
- Abionic develops the abioSCOPE, a nanofluidics-based rapid diagnostics platform that runs a PSP biomarker assay to detect sepsis from a drop of blood within minutes. The system is aimed at emergency and critical care clinicians to enable earlier sepsis detection and intervention.
- Who are Abionic's investors?
- Abionic's investors include Polytech Ecosystem Ventures.